On average, patients using Ozempic for an extended period lose about 6-10% of their body weight, or roughly 13–15 pounds (6–6.8 kg). When used at the higher 2.4 mg dose (marketed as Wegovy for weight loss), the average loss increases to approximately 15% of body weight over 68 weeks.
Most people lose around 1kg or 1.1% of their body weight in their first month on Ozempic, according to data from randomised controlled trials1.
Most patients lose 1 to 2 pounds per week with Semaglutide. That means a 20-pound loss is achievable within 10 to 16 weeks when the medication is used correctly and paired with supportive habits. Some people reach this milestone faster, especially if they begin with a higher starting weight.
There is a positive impact of Ozempic and other GLP-1s
These medications can lead to ~15–20 percent weight loss on average, which is significantly more than older medications.
After six weeks, Dr. Shah says that you should start to feel the effects of the medication—which may mean that you do not feel as hungry as you normally would be. But, again, everyone is different. Tanya Gulliver-Garcia started taking Ozempic a few months ago to help manage her type 2 diabetes.
Key Milestones for Weight Loss with Ozempic
What can I do to maximize weight loss while using Ozempic?
Will Ozempic or Wegovy reduce belly fat? The answer appears to be yes. That Novo Nordisk-funded study of almost 2,000 overweight or obese adults without diabetes also found their visceral fat — the type that accumulates in the belly — was reduced from baseline with semaglutide, along with their total fat mass.
'Ozempic legs' is an informal term describing visible changes in leg appearance—such as reduced fat volume, increased muscle and vein visibility, and looser skin—that some people experience during treatment with semaglutide (Ozempic) or similar GLP-1 receptor agonists.
"Ozempic face," the gaunt look from rapid facial fat loss, doesn't automatically go away but can improve if you regain weight or through cosmetic treatments like fillers, as the skin's ability to bounce back depends on age and elasticity; maintaining weight loss means the facial changes likely persist unless addressed with procedures.
Ozempic and other GLP-1 drugs reduce food intake by stimulating a feeling of fullness. They act on the brain to promote satiety and on the gut to slow the movement of food through the stomach, helping people feel full longer. As a result, people on the drugs lose weight because they eat less.
"Ozempic hands" is a slang term for the visible changes in hands due to rapid fat loss from GLP-1 drugs like Ozempic, making them look thinner, bonier, and more aged with prominent veins, tendons, and thinner skin, as subcutaneous fat diminishes and skin doesn't fully contract quickly. It's not a formal diagnosis but a common cosmetic effect of significant weight loss, similar to "Ozempic face".
How Does Ozempic Work in the Brain? Ozempic influences brain function through its action as a glucagon-like peptide-1 (GLP-1) receptor agonist, primarily targeting regions involved in appetite regulation, reward processing, and metabolic signaling.
There's no direct interaction between alcohol and Ozempic. But alcohol might sabotage some of Ozempic's potential benefits for your body weight, kidneys, and heart. And the combination may also worsen Ozempic's side effects. An occasional drink or two with Ozempic may not be a big deal.
Ozempic helps people lose weight by making them feel full, so they eat less. You may well be wondering whether that means you need to make any changes to your diet while taking it. The answer is yes, you do.
Nausea is the most common Ozempic side effect. Still, not everyone has it. About 1 in 5 people in the clinical trial had it. Nausea is usually mild to moderate and at its worst when you first start the drug or when you increase your dose.
Rapid weight loss is a significant factor in the development of 'Ozempic Face. ' To minimize its impact, aim for a steady and gradual weight loss. This approach allows your skin more time to adjust and tighten naturally, reducing the risk of a gaunt appearance.
You can't definitively tell if someone used Ozempic without a medical test, but significant, rapid weight loss might suggest it, causing "Ozempic Face"—hollow cheeks, sunken eyes, sagging skin, and wrinkles—due to fat loss and muscle loss, though any quick weight loss causes these signs. Other clues are typical Ozempic side effects like nausea, diarrhea, or constipation, but these also occur with other conditions. Only a doctor can confirm use through specific blood tests monitoring GLP-1 levels.
But about half of people with obesity on this class of medications, called glucagon-like peptide agonists or GLP-1s, stop taking it within a year. Studies suggest that most people discontinue their use due to the high cost and adverse gastrointestinal side-effects.
“Some patients will experience a loss of appetite with the initial dose,” he says. “However, most patients will likely not see significant weight loss until they reach higher dose levels at eight-to-12 weeks.” In Dr. Lofton's experience, there is usually some weight loss in the first month.
It is not known if Ozempic® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Do not use Ozempic® if you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Yes, you can lose weight without exercise on Ozempic®, but the medication is usually prescribed alongside exercise. It might not be as effective without exercise. Talk to your healthcare provider about forms of movement you can do and other tips to manage your weight and blood sugar levels, if needed.
General Guidelines for Eating on Ozempic
The emergence of weight-loss drugs (agonists) including Ozempic and Wegovy has turned the medical world upside down in recent years. Glucogen-like peptide 1 (GLP-1) agonists have proved effective in helping obese people lose weight by reducing the users' appetite, so they eat less.